SkinbiotherapeuticsSBTX 
$0.14-0.94%24h
-0.94%24h
Global rank28628
Market cap$22.88M
Change 7d-18.25%
YTD Performance-30.98%
SP500 benchmarkUnderperform
P/E-8.08
P/S131.28
Revenue$174.32K
Earnings-$3.74M
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Skinbiotherapeutics (SBTX)
As of November 2024, Skinbiotherapeutics has a market cap of $22.88M. This makes Skinbiotherapeutics the world's 28628th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Skinbiotherapeutics from 2017 to 2024
-
Value:-
Market cap history of Skinbiotherapeutics from 2017 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $23.37M | -29.51% |
| 2023 | $33.16M | -1.61% |
| 2022 | $33.70M | -63.10% |
| 2021 | $91.32M | 78.72% |
| 2020 | $51.09M | 62.50% |
| 2019 | $31.44M | 7.41% |
| 2018 | $29.27M | 47.95% |
| 2017 | $19.79M | - |
SBTX Market Cap Today is $22.88M -0.94% - 11 Nov 2024
View largest stocks by market cap 
